P450 CYP2C epoxygenase and CYP4A ω-hydroxylase mediate ciprofibrate-induced PPARα-dependent peroxisomal proliferation

Peroxisomal proliferators, such as ciprofibrate, are used extensively as effective hypolipidemic drugs. The effects of these compounds on lipid metabolism require ligand binding activation of the peroxisome proliferator-activated receptor (PPAR) α subtype of nuclear receptors and involve transcripti...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Arnaldo Gatica, Mauricio C. Aguilera, David Contador, Gloria Loyola, Claudio O. Pinto, Ludwig Amigo, Juan E. Tichauer, Silvana Zanlungo, Miguel Bronfman
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2007-04-01
Serie:	Journal of Lipid Research
Soggetti:	P450 monooxygenases ω-hydroxylated-eicosatrienoic acids peroxisome proliferator-activated receptor α
Accesso online:	http://www.sciencedirect.com/science/article/pii/S0022227520434455
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!